By significantly slowing the rate at which the stomach empties its contents, the medication may contribute to gastroesophageal reflux disease (GERD), which is listed as an adverse reaction in the Wegovy prescribing information
Benefits Semaglutide and liraglutide share a few common benefits, such as: Both drugs promote blood sugar control in patients with type 2 diabetes Semaglutide (Wegovy) and liraglutide (Saxenda) help reduce body weight in obese and overweight patients Both drugs have potential cardiovascular benefits and reduce the risk of heart attack, stroke, and cardiovascular death Side effects As semaglutide and liraglutide belong to the same class of drugs (GLP-1 receptor agonist), they have common side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, injection site reaction, and pancreatitis
Ozempic-type drugs mimic GLP-1, thereby tricking our body into thinking were eating all the time
[Its] very common and really depends on the rate of weight loss, explains Dr